Swiss Pharmaceuticals & Biotech Blue chip stocks

Sandoz Group

Market Cap: CHF 31.4b

Develops, manufactures, and markets generic and biosimilars worldwide.

Galderma Group

Market Cap: CHF 41.0b

Operates as a dermatology company worldwide.

Lonza Group

Market Cap: CHF 39.5b

Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.